Replies to post #424086 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I agree with your market cap prediction.
But please keep in mind that the 15X revenue multiple (recent ISI number) is based on actual realized revenue by NVCR over 2020 and not its prognose for 20021 or 2022 (which looks pretty grim after DCVAX L is approved).

Since DCVAX L revenue could grow as big as 3 billion, x15 would mean a MC of 30 billion in the future and at least 50% of that after or just before approval.

I believe NVCR MC has diminished because of the redefinition of GBM by WHO which should put the Helmet out of business if the FDA was any backbone they should revoke the Helmets license now IMO.